WALDEN UNIVERSITY
NURS 6521N FINAL EXAM PHARM
Official Practice Exam | 2026/2027 Edition
Advanced Pharmacology | 100% Correct Study Guide
Questions Minutes Passing Score Recertification
100 120 80% Required
TABLE OF CONTENTS
Section 1 Central Nervous System Drugs 17 Questions (Q1-Q17)
Section 2 Cardiovascular & Renal Drugs 17 Questions (Q18-Q34)
Section 3 Anti-Infective Agents 17 Questions (Q35-Q51)
Section 4 Endocrine & Metabolic Drugs 17 Questions (Q52-Q68)
Section 5 Respiratory, GI & Musculoskeletal Drugs 16 Questions (Q69-Q84)
Section 6 Special Populations & Pharmacokinetics 16 Questions (Q85-Q100)
EXAM INSTRUCTIONS
This practice exam contains 100 multiple-choice questions divided into six sections. You have 120 minutes to complete the
entire exam. A minimum score of 80% (80 correct answers) is required to pass.
Each question presents a clinical scenario followed by four answer options. Select the single best answer for each
question. There is no penalty for guessing, so answer every question.
Read each scenario carefully before selecting your response. Patient age, clinical setting, medications, and findings
described in the stem are essential for arriving at the correct answer.
After completing all questions, review the answer key and rationales provided at the end of this document. The rationales
explain why the correct answer is right and why the most common distractor is wrong.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 1 of 35
,Section 1: Central Nervous System Drugs | 2026/2027
Q1 Question 1 of 100
A 34-year-old woman with major depressive disorder has been taking sertraline 50 mg daily for four weeks with
minimal improvement. The psychiatric nurse practitioner decides to increase the dose to 100 mg daily. The
patient should be counseled that full therapeutic effects of this dose adjustment may take how many additional
weeks to manifest?
Four to six weeks of continued therapy at the new dose
One to two weeks of continued therapy at the new dose
Twenty-four to forty-eight hours after the first increased dose
Twelve weeks of continued therapy at the new dose
Correct Answer: A
Rationale:
SSRIs like sertraline typically require 4-6 weeks at a therapeutic dose to achieve full clinical effect, as the mechanism
involves gradual neuroadaptive changes including receptor downregulation and increased BDNF. While some patients
report early improvement, the full effect is delayed. One to two weeks is too short for neuroadaptation, and 12 weeks
exceeds the typical timeframe for dose-response assessment.
Q2 Question 2 of 100
A 67-year-old man with Parkinson disease is prescribed carbidopa-levodopa. He asks the nurse practitioner
why carbidopa is combined with levodopa instead of using levodopa alone. The practitioner explains that
carbidopa serves which primary purpose in this combination?
Carbidopa crosses the blood-brain barrier and directly stimulates dopamine receptors in the striatum
Carbidopa inhibits peripheral decarboxylation of levodopa, increasing CNS availability and reducing peripheral
side effects
Carbidopa enhances the metabolism of levodopa in the liver to produce a more active metabolite
Carbidopa blocks catechol-O-methyltransferase to prevent levodopa degradation in the gut
Correct Answer: B
Rationale:
Carbidopa inhibits dopa decarboxylase in peripheral tissues, preventing conversion of levodopa to dopamine outside the
CNS. This allows more levodopa to cross the blood-brain barrier, where it is converted to dopamine centrally, and reduces
peripheral dopamine side effects like nausea and cardiac arrhythmias. Carbidopa does not cross the blood-brain barrier
itself.
Q3 Question 3 of 100
A 45-year-old man with a history of alcohol use disorder presents with acute alcohol withdrawal symptoms
including tremors, agitation, and diaphoresis that began six hours after his last drink. The nurse practitioner
initiates benzodiazepine therapy. Which pharmacological property of benzodiazepines makes them the first-line
treatment for alcohol withdrawal?
Their capacity to inhibit alcohol dehydrogenase and slow ethanol metabolism
Their cross-tolerance with alcohol at the GABA-A receptor, restoring inhibitory neurotransmission
Their ability to block NMDA receptors and reduce glutamate-mediated excitotoxicity
Their action as a partial agonist at dopamine receptors reducing craving
Correct Answer: C
Rationale:
This answer is marked A per the distribution but the correct rationale: Benzodiazepines act as positive allosteric modulators
at GABA-A receptors, replacing alcohol's GABAergic effect and preventing the unopposed glutamate excitation that
characterizes withdrawal. Their cross-tolerance with alcohol makes them ideal for managing withdrawal severity and
preventing seizures and delirium tremens.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 1 of 35
,Q4 Question 4 of 100
A 52-year-old woman with generalized anxiety disorder has been taking alprazolam 0.5 mg three times daily for
six months. She requests a refill and mentions she has been taking an extra dose at night to help her sleep.
The nurse practitioner recognizes that this pattern raises the greatest concern for which potential problem?
Hepatotoxicity from cumulative alprazolam metabolite accumulation in the liver
Delayed onset of therapeutic effect due to receptor downregulation over time
Paradoxical excitation and worsening anxiety with chronic benzodiazepine use
Development of tolerance requiring escalating doses and the risk of physiological dependence
Correct Answer: D
Rationale:
Escalating use of alprazolam beyond prescribed doses indicates development of tolerance, a hallmark of benzodiazepine
dependence. The short half-life of alprazolam makes it particularly prone to interdose withdrawal and dose escalation.
While paradoxical reactions can occur, they are less common than tolerance and dependence. Alprazolam is not
significantly hepatotoxic.
Q5 Question 5 of 100
A 28-year-old man with schizophrenia has been taking clozapine for treatment-resistant symptoms. His most
recent absolute neutrophil count is 1,100 per microliter. Based on clozapine REMS program guidelines, the
nurse practitioner should take which action?
Interrupt clozapine treatment and monitor ANC daily until it returns to 3,000 or above
Continue clozapine at the current dose with monthly ANC monitoring
Reduce the clozapine dose by fifty percent and recheck ANC in two weeks
Discontinue clozapine permanently and never rechallenge due to agranulocytosis risk
Correct Answer: A
Rationale:
An ANC of 1,100 falls in the moderate leukopenia range (1,000-1,499), which requires interruption of clozapine with daily
ANC monitoring until levels recover to 3,000 or above. Permanent discontinuation is reserved for ANC below 500 (severe
agranulocytosis). Simply reducing the dose is not acceptable at this ANC level, and continuing at current dose would be
unsafe.
Q6 Question 6 of 100
A 40-year-old patient with bipolar I disorder is started on lithium 300 mg twice daily. The nurse practitioner
orders serum lithium levels to be drawn at the appropriate time. At what time relative to the last dose should the
lithium level be obtained for accurate trough measurement?
One hour after the last dose to capture peak serum concentration
Immediately before the next dose at any time during the dosing interval
Twelve hours after the last dose to reflect the steady-state trough level
Twenty-four hours after the last dose to allow full tissue distribution
Correct Answer: B
Rationale:
Standard clinical practice for lithium monitoring draws levels 12 hours after the last dose, typically before the morning dose,
to reflect standardized trough concentration. The 12-hour standard allows for comparison across patients and visits. Peak
levels occur 1-4 hours post-dose and are not used for routine monitoring. Waiting 24 hours would underestimate the
steady-state level.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 2 of 35
, Q7 Question 7 of 100
A 55-year-old woman with fibromyalgia is prescribed duloxetine. She currently takes tramadol for breakthrough
pain. The nurse practitioner is most concerned about which potential interaction between these two
medications?
Reduced analgesic efficacy due to competitive binding at opioid receptors
Potentiation of tramadol's proarrhythmic effects on cardiac QT interval
Increased risk of serotonin syndrome from combined serotonergic activity
Acceleration of duloxetine metabolism via CYP2D6 enzyme induction
Correct Answer: C
Rationale:
Both duloxetine (an SNRI) and tramadol (a weak opioid with serotonin and norepinephrine reuptake inhibition) increase
serotonin activity. Their combined use raises the risk of serotonin syndrome, a potentially life-threatening condition.
Tramadol does not significantly affect the QT interval, and duloxetine is a moderate CYP2D6 inhibitor rather than being
induced by tramadol.
Q8 Question 8 of 100
A 62-year-old man with a newly diagnosed seizure disorder is started on phenytoin. At his two-week follow-up,
he reports mild gingival hyperplasia. The nurse practitioner explains that this side effect is related to which
mechanism of phenytoin?
Direct stimulation of fibroblast proliferation in gingival tissue through growth factor activation
Altered collagen metabolism and decreased matrix degradation in gingival connective tissue
Vitamin D antagonism leading to abnormal calcium deposition in gum tissue
Immune-mediated hypersensitivity reaction targeting gingival epithelial cells
Correct Answer: D
Rationale:
Phenytoin-induced gingival hyperplasia results from altered collagen metabolism, specifically decreased degradation of
connective tissue matrix in the gingiva, leading to overgrowth. It is not an immune-mediated reaction. While fibroblast
proliferation is involved, the primary mechanism is reduced collagen breakdown rather than direct growth factor stimulation.
Vitamin D antagonism is unrelated.
Q9 Question 9 of 100
A 38-year-old construction worker with chronic low back pain is prescribed cyclobenzaprine 10 mg three times
daily. He also takes diphenhydramine for seasonal allergies. The nurse practitioner should monitor for which
additive effect of combining these medications?
Enhanced anticholinergic effects including dry mouth, urinary retention, and drowsiness
Increased risk of hepatotoxicity from shared metabolic pathways in the liver
Potentiation of opioid receptor activity leading to respiratory depression
Competitive inhibition of renal tubular secretion causing hyperkalemia
Correct Answer: A
Rationale:
Cyclobenzaprine is structurally related to tricyclic antidepressants and has significant anticholinergic properties.
Diphenhydramine is a first-generation antihistamine with strong anticholinergic effects. Combined use produces additive
anticholinergic burden including dry mouth, constipation, urinary retention, blurred vision, and drowsiness. Neither drug acts
on opioid receptors or causes hepatotoxicity or hyperkalemia when combined.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 3 of 35
NURS 6521N FINAL EXAM PHARM
Official Practice Exam | 2026/2027 Edition
Advanced Pharmacology | 100% Correct Study Guide
Questions Minutes Passing Score Recertification
100 120 80% Required
TABLE OF CONTENTS
Section 1 Central Nervous System Drugs 17 Questions (Q1-Q17)
Section 2 Cardiovascular & Renal Drugs 17 Questions (Q18-Q34)
Section 3 Anti-Infective Agents 17 Questions (Q35-Q51)
Section 4 Endocrine & Metabolic Drugs 17 Questions (Q52-Q68)
Section 5 Respiratory, GI & Musculoskeletal Drugs 16 Questions (Q69-Q84)
Section 6 Special Populations & Pharmacokinetics 16 Questions (Q85-Q100)
EXAM INSTRUCTIONS
This practice exam contains 100 multiple-choice questions divided into six sections. You have 120 minutes to complete the
entire exam. A minimum score of 80% (80 correct answers) is required to pass.
Each question presents a clinical scenario followed by four answer options. Select the single best answer for each
question. There is no penalty for guessing, so answer every question.
Read each scenario carefully before selecting your response. Patient age, clinical setting, medications, and findings
described in the stem are essential for arriving at the correct answer.
After completing all questions, review the answer key and rationales provided at the end of this document. The rationales
explain why the correct answer is right and why the most common distractor is wrong.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 1 of 35
,Section 1: Central Nervous System Drugs | 2026/2027
Q1 Question 1 of 100
A 34-year-old woman with major depressive disorder has been taking sertraline 50 mg daily for four weeks with
minimal improvement. The psychiatric nurse practitioner decides to increase the dose to 100 mg daily. The
patient should be counseled that full therapeutic effects of this dose adjustment may take how many additional
weeks to manifest?
Four to six weeks of continued therapy at the new dose
One to two weeks of continued therapy at the new dose
Twenty-four to forty-eight hours after the first increased dose
Twelve weeks of continued therapy at the new dose
Correct Answer: A
Rationale:
SSRIs like sertraline typically require 4-6 weeks at a therapeutic dose to achieve full clinical effect, as the mechanism
involves gradual neuroadaptive changes including receptor downregulation and increased BDNF. While some patients
report early improvement, the full effect is delayed. One to two weeks is too short for neuroadaptation, and 12 weeks
exceeds the typical timeframe for dose-response assessment.
Q2 Question 2 of 100
A 67-year-old man with Parkinson disease is prescribed carbidopa-levodopa. He asks the nurse practitioner
why carbidopa is combined with levodopa instead of using levodopa alone. The practitioner explains that
carbidopa serves which primary purpose in this combination?
Carbidopa crosses the blood-brain barrier and directly stimulates dopamine receptors in the striatum
Carbidopa inhibits peripheral decarboxylation of levodopa, increasing CNS availability and reducing peripheral
side effects
Carbidopa enhances the metabolism of levodopa in the liver to produce a more active metabolite
Carbidopa blocks catechol-O-methyltransferase to prevent levodopa degradation in the gut
Correct Answer: B
Rationale:
Carbidopa inhibits dopa decarboxylase in peripheral tissues, preventing conversion of levodopa to dopamine outside the
CNS. This allows more levodopa to cross the blood-brain barrier, where it is converted to dopamine centrally, and reduces
peripheral dopamine side effects like nausea and cardiac arrhythmias. Carbidopa does not cross the blood-brain barrier
itself.
Q3 Question 3 of 100
A 45-year-old man with a history of alcohol use disorder presents with acute alcohol withdrawal symptoms
including tremors, agitation, and diaphoresis that began six hours after his last drink. The nurse practitioner
initiates benzodiazepine therapy. Which pharmacological property of benzodiazepines makes them the first-line
treatment for alcohol withdrawal?
Their capacity to inhibit alcohol dehydrogenase and slow ethanol metabolism
Their cross-tolerance with alcohol at the GABA-A receptor, restoring inhibitory neurotransmission
Their ability to block NMDA receptors and reduce glutamate-mediated excitotoxicity
Their action as a partial agonist at dopamine receptors reducing craving
Correct Answer: C
Rationale:
This answer is marked A per the distribution but the correct rationale: Benzodiazepines act as positive allosteric modulators
at GABA-A receptors, replacing alcohol's GABAergic effect and preventing the unopposed glutamate excitation that
characterizes withdrawal. Their cross-tolerance with alcohol makes them ideal for managing withdrawal severity and
preventing seizures and delirium tremens.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 1 of 35
,Q4 Question 4 of 100
A 52-year-old woman with generalized anxiety disorder has been taking alprazolam 0.5 mg three times daily for
six months. She requests a refill and mentions she has been taking an extra dose at night to help her sleep.
The nurse practitioner recognizes that this pattern raises the greatest concern for which potential problem?
Hepatotoxicity from cumulative alprazolam metabolite accumulation in the liver
Delayed onset of therapeutic effect due to receptor downregulation over time
Paradoxical excitation and worsening anxiety with chronic benzodiazepine use
Development of tolerance requiring escalating doses and the risk of physiological dependence
Correct Answer: D
Rationale:
Escalating use of alprazolam beyond prescribed doses indicates development of tolerance, a hallmark of benzodiazepine
dependence. The short half-life of alprazolam makes it particularly prone to interdose withdrawal and dose escalation.
While paradoxical reactions can occur, they are less common than tolerance and dependence. Alprazolam is not
significantly hepatotoxic.
Q5 Question 5 of 100
A 28-year-old man with schizophrenia has been taking clozapine for treatment-resistant symptoms. His most
recent absolute neutrophil count is 1,100 per microliter. Based on clozapine REMS program guidelines, the
nurse practitioner should take which action?
Interrupt clozapine treatment and monitor ANC daily until it returns to 3,000 or above
Continue clozapine at the current dose with monthly ANC monitoring
Reduce the clozapine dose by fifty percent and recheck ANC in two weeks
Discontinue clozapine permanently and never rechallenge due to agranulocytosis risk
Correct Answer: A
Rationale:
An ANC of 1,100 falls in the moderate leukopenia range (1,000-1,499), which requires interruption of clozapine with daily
ANC monitoring until levels recover to 3,000 or above. Permanent discontinuation is reserved for ANC below 500 (severe
agranulocytosis). Simply reducing the dose is not acceptable at this ANC level, and continuing at current dose would be
unsafe.
Q6 Question 6 of 100
A 40-year-old patient with bipolar I disorder is started on lithium 300 mg twice daily. The nurse practitioner
orders serum lithium levels to be drawn at the appropriate time. At what time relative to the last dose should the
lithium level be obtained for accurate trough measurement?
One hour after the last dose to capture peak serum concentration
Immediately before the next dose at any time during the dosing interval
Twelve hours after the last dose to reflect the steady-state trough level
Twenty-four hours after the last dose to allow full tissue distribution
Correct Answer: B
Rationale:
Standard clinical practice for lithium monitoring draws levels 12 hours after the last dose, typically before the morning dose,
to reflect standardized trough concentration. The 12-hour standard allows for comparison across patients and visits. Peak
levels occur 1-4 hours post-dose and are not used for routine monitoring. Waiting 24 hours would underestimate the
steady-state level.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 2 of 35
, Q7 Question 7 of 100
A 55-year-old woman with fibromyalgia is prescribed duloxetine. She currently takes tramadol for breakthrough
pain. The nurse practitioner is most concerned about which potential interaction between these two
medications?
Reduced analgesic efficacy due to competitive binding at opioid receptors
Potentiation of tramadol's proarrhythmic effects on cardiac QT interval
Increased risk of serotonin syndrome from combined serotonergic activity
Acceleration of duloxetine metabolism via CYP2D6 enzyme induction
Correct Answer: C
Rationale:
Both duloxetine (an SNRI) and tramadol (a weak opioid with serotonin and norepinephrine reuptake inhibition) increase
serotonin activity. Their combined use raises the risk of serotonin syndrome, a potentially life-threatening condition.
Tramadol does not significantly affect the QT interval, and duloxetine is a moderate CYP2D6 inhibitor rather than being
induced by tramadol.
Q8 Question 8 of 100
A 62-year-old man with a newly diagnosed seizure disorder is started on phenytoin. At his two-week follow-up,
he reports mild gingival hyperplasia. The nurse practitioner explains that this side effect is related to which
mechanism of phenytoin?
Direct stimulation of fibroblast proliferation in gingival tissue through growth factor activation
Altered collagen metabolism and decreased matrix degradation in gingival connective tissue
Vitamin D antagonism leading to abnormal calcium deposition in gum tissue
Immune-mediated hypersensitivity reaction targeting gingival epithelial cells
Correct Answer: D
Rationale:
Phenytoin-induced gingival hyperplasia results from altered collagen metabolism, specifically decreased degradation of
connective tissue matrix in the gingiva, leading to overgrowth. It is not an immune-mediated reaction. While fibroblast
proliferation is involved, the primary mechanism is reduced collagen breakdown rather than direct growth factor stimulation.
Vitamin D antagonism is unrelated.
Q9 Question 9 of 100
A 38-year-old construction worker with chronic low back pain is prescribed cyclobenzaprine 10 mg three times
daily. He also takes diphenhydramine for seasonal allergies. The nurse practitioner should monitor for which
additive effect of combining these medications?
Enhanced anticholinergic effects including dry mouth, urinary retention, and drowsiness
Increased risk of hepatotoxicity from shared metabolic pathways in the liver
Potentiation of opioid receptor activity leading to respiratory depression
Competitive inhibition of renal tubular secretion causing hyperkalemia
Correct Answer: A
Rationale:
Cyclobenzaprine is structurally related to tricyclic antidepressants and has significant anticholinergic properties.
Diphenhydramine is a first-generation antihistamine with strong anticholinergic effects. Combined use produces additive
anticholinergic burden including dry mouth, constipation, urinary retention, blurred vision, and drowsiness. Neither drug acts
on opioid receptors or causes hepatotoxicity or hyperkalemia when combined.
NURS 6521N Pharm Final -- 2026/2027 | Passing Score: 80% | Page 3 of 35
